• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

选择性抑制 ACE（血管紧张素转换酶）的 C 端结构域与抑制 NEP（中性内肽酶）联合应用：高血压治疗的一种新方法。

Selective Inhibition of the C-Domain of ACE (Angiotensin-Converting Enzyme) Combined With Inhibition of NEP (Neprilysin): A Potential New Therapy for Hypertension.

机构信息

Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom (R.A.-L., A.C.M., K.B.N., A.H., F.J.R., D.S.S., T.J.G., D.G., R.M.T.).

Institute of Infectious Disease and Molecular Medicine and Division of Medical Biochemistry, University of Cape Town, South Africa (L.B.A., E.S.).

出版信息

Hypertension. 2021 Sep;78(3):604-616. doi: 10.1161/HYPERTENSIONAHA.121.17041. Epub 2021 Jul 26.

DOI:10.1161/HYPERTENSIONAHA.121.17041
PMID:34304582
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8357049/
Abstract

[Figure: see text].

摘要

[图：见正文]。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b668/8357049/8bb24d1c5c6b/hyp-78-604-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b668/8357049/2b5d62a711c7/hyp-78-604-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b668/8357049/bf9358139be0/hyp-78-604-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b668/8357049/a0c06e5a3e46/hyp-78-604-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b668/8357049/8f4bde7bfc3e/hyp-78-604-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b668/8357049/3ab5ea7a6856/hyp-78-604-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b668/8357049/8bb24d1c5c6b/hyp-78-604-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b668/8357049/2b5d62a711c7/hyp-78-604-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b668/8357049/bf9358139be0/hyp-78-604-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b668/8357049/a0c06e5a3e46/hyp-78-604-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b668/8357049/8f4bde7bfc3e/hyp-78-604-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b668/8357049/3ab5ea7a6856/hyp-78-604-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b668/8357049/8bb24d1c5c6b/hyp-78-604-g006.jpg

相似文献

1
Selective Inhibition of the C-Domain of ACE (Angiotensin-Converting Enzyme) Combined With Inhibition of NEP (Neprilysin): A Potential New Therapy for Hypertension.选择性抑制 ACE（血管紧张素转换酶）的 C 端结构域与抑制 NEP（中性内肽酶）联合应用：高血压治疗的一种新方法。
Hypertension. 2021 Sep;78(3):604-616. doi: 10.1161/HYPERTENSIONAHA.121.17041. Epub 2021 Jul 26.
2
Comparison of angiotensin-converting enzyme (ACE), neutral endopeptidase (NEP) and dual ACE/NEP inhibition on blood pressure and resistance arteries of deoxycorticosterone acetate-salt hypertensive rats.血管紧张素转换酶（ACE）、中性内肽酶（NEP）以及ACE/NEP双重抑制对醋酸脱氧皮质酮盐高血压大鼠血压和阻力动脉的影响比较
J Hypertens. 2002 May;20(5):899-907. doi: 10.1097/00004872-200205000-00025.
3
Effect of dual angiotensin converting enzyme/neutral endopeptidase inhibition, angiotensin converting enzyme inhibition, or AT1 antagonism on coronary microvasculature in spontaneously hypertensive rats.双重血管紧张素转换酶/中性内肽酶抑制、血管紧张素转换酶抑制或AT1拮抗对自发性高血压大鼠冠状动脉微血管的影响。
Am J Hypertens. 2003 Nov;16(11 Pt 1):931-7. doi: 10.1016/s0895-7061(03)01029-x.
4
Effects of omapatrilat in low, normal, and high renin experimental hypertension.奥帕曲拉在低肾素、正常肾素和高肾素实验性高血压中的作用。
Am J Hypertens. 1998 Mar;11(3 Pt 1):363-72. doi: 10.1016/s0895-7061(97)00404-4.
5
Effects of omapatrilat on pharmacodynamic biomarkers of neutral endopeptidase and Angiotensin-converting enzyme activity in humans.奥帕曲拉对人体中性内肽酶和血管紧张素转换酶活性的药效学生物标志物的影响。
Curr Hypertens Rep. 2001 Dec;3 Suppl 2:S22-7. doi: 10.1007/s11906-001-0103-x.
6
Anti-atherosclerotic and renoprotective effects of combined angiotensin-converting enzyme and neutral endopeptidase inhibition in diabetic apolipoprotein E-knockout mice.联合抑制血管紧张素转换酶和中性内肽酶对糖尿病载脂蛋白E基因敲除小鼠的抗动脉粥样硬化和肾脏保护作用
J Hypertens. 2005 Nov;23(11):2071-82. doi: 10.1097/01.hjh.0000184747.41565.a1.
7
Dual inhibition of angiotensin converting enzyme and neutral endopeptidase produces effective blood pressure control in spontaneously hypertensive rats.血管紧张素转换酶和中性内肽酶的双重抑制可有效控制自发性高血压大鼠的血压。
Bratisl Lek Listy. 2005;106(12):407-11.
8
Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension.在原发性高血压中，sampatrilat对中性内肽酶和血管紧张素转换酶的联合抑制作用
Clin Pharmacol Ther. 1998 Oct;64(4):439-49. doi: 10.1016/S0009-9236(98)90075-3.
9
Concomitant angiotensin AT1 receptor antagonism and neprilysin inhibition produces omapatrilat-like antihypertensive effects without promoting tracheal plasma extravasation in the rat.同时拮抗血管紧张素 AT1 受体和抑制 Neprilysin 可产生与 Omapatrilat 相似的降压作用，而不会促进大鼠气管血浆外渗。
J Cardiovasc Pharmacol. 2011 Apr;57(4):495-504. doi: 10.1097/FJC.0b013e318210fc7e.
10
Dual angiotensin-converting enzyme/neutral endopeptidase inhibition on cardiac and renal fibrosis and inflammation in DOCA-salt hypertensive rats.双重血管紧张素转换酶/中性内肽酶抑制对去氧皮质酮盐高血压大鼠心脏和肾脏纤维化及炎症的影响
J Hypertens. 2005 Feb;23(2):401-9. doi: 10.1097/00004872-200502000-00023.

引用本文的文献

1
Research Progress on the Mechanism of Action of Food-Derived ACE-Inhibitory Peptides.食物源ACE抑制肽作用机制的研究进展
Life (Basel). 2025 Aug 1;15(8):1219. doi: 10.3390/life15081219.
2
Exploring hypertension-linked diseases: a comprehensive review of innovative drug combinations with enhanced therapeutic potential.探索与高血压相关的疾病：对具有增强治疗潜力的创新药物组合的全面综述。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan 31. doi: 10.1007/s00210-025-03819-3.
3
Targeting the Renin-angiotensin-aldosterone System (RAAS) for Cardiovascular Protection and Enhanced Oncological Outcomes: Review.

本文引用的文献

1
Inflammation in Hypertension.高血压中的炎症反应。
Can J Cardiol. 2020 May;36(5):635-647. doi: 10.1016/j.cjca.2020.01.013. Epub 2020 Jan 24.
2
Hypertension Awareness, Treatment, and Control in US Adults: Trends in the Hypertension Control Cascade by Population Subgroup (National Health and Nutrition Examination Survey, 1999-2016).美国成年人的高血压知晓率、治疗率和控制率：按人口亚组分析高血压控制级联的趋势（1999-2016 年国家健康和营养调查）。
Am J Epidemiol. 2019 Dec 31;188(12):2165-2174. doi: 10.1093/aje/kwz177.
3
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
靶向肾素-血管紧张素-醛固酮系统（RAAS）以保护心血管和改善肿瘤学结局：综述。
Curr Treat Options Oncol. 2024 Nov;25(11):1406-1427. doi: 10.1007/s11864-024-01270-9. Epub 2024 Oct 18.
4
Phytochemical Investigation of Schreb. and ACE-Inhibitory Activity of Oligomer Stilbenes of the Plant.植物 Schreb. 的化学生物学研究及该植物低聚二苯乙烯的 ACE 抑制活性。
Molecules. 2024 Jul 22;29(14):3427. doi: 10.3390/molecules29143427.
5
Advances in the structural basis for angiotensin-1 converting enzyme (ACE) inhibitors.血管紧张素转化酶（ACE）抑制剂结构基础研究进展。
Biosci Rep. 2024 Aug 28;44(8). doi: 10.1042/BSR20240130.
6
Proteomic Analysis of Human Macrophages Overexpressing Angiotensin-Converting Enzyme.人血管紧张素转化酶过表达巨噬细胞的蛋白质组学分析
Int J Mol Sci. 2024 Jun 27;25(13):7055. doi: 10.3390/ijms25137055.
7
ACE inhibitors and their interaction with systems and molecules involved in metabolism.血管紧张素转换酶抑制剂及其与参与代谢的系统和分子的相互作用。
Heliyon. 2024 Jan 14;10(2):e24655. doi: 10.1016/j.heliyon.2024.e24655. eCollection 2024 Jan 30.
8
Is It Still Relevant to Discover New ACE Inhibitors from Natural Products? YES, but Only with Comprehensive Approaches to Address the Patients' Real Problems: Chronic Dry Cough and Angioedema.从天然产物中发现新型 ACE 抑制剂是否仍然具有意义？是的，但只有采用综合方法解决患者的实际问题（慢性干咳和血管性水肿）才具有意义。
Molecules. 2023 Jun 2;28(11):4532. doi: 10.3390/molecules28114532.
9
Exploring the Impact of ACE Inhibition in Immunity and Disease.探讨 ACE 抑制在免疫和疾病中的作用。
J Renin Angiotensin Aldosterone Syst. 2022 Aug 4;2022:9028969. doi: 10.1155/2022/9028969. eCollection 2022.
10
TRPM7 deficiency exacerbates cardiovascular and renal damage induced by aldosterone-salt.TRPM7 缺乏加剧醛固酮-盐诱导的心血管和肾脏损伤。
Commun Biol. 2022 Jul 26;5(1):746. doi: 10.1038/s42003-022-03715-z.
血管紧张素-脑啡肽酶抑制剂在射血分数保留的心力衰竭中的应用。
N Engl J Med. 2019 Oct 24;381(17):1609-1620. doi: 10.1056/NEJMoa1908655. Epub 2019 Sep 1.
4
Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys.12 个高收入国家高血压知晓率、治疗率和控制率的长期和近期趋势：对 123 项全国代表性调查的分析。
Lancet. 2019 Aug 24;394(10199):639-651. doi: 10.1016/S0140-6736(19)31145-6. Epub 2019 Jul 18.
5
Angiotensin-Converting Enzyme Inhibitors Induce Cough.血管紧张素转换酶抑制剂会引发咳嗽。
Turk Thorac J. 2019 Jan 1;20(1):36-42. doi: 10.5152/TurkThoracJ.2018.18014.
6
Molecular Basis for Multiple Omapatrilat Binding Sites within the ACE C-Domain: Implications for Drug Design.分子基础多个奥美沙坦酯结合位点在 ACE C 域：对药物设计的影响。
J Med Chem. 2018 Nov 21;61(22):10141-10154. doi: 10.1021/acs.jmedchem.8b01309. Epub 2018 Nov 7.
7
Neprilysin Inhibitors and Bradykinin.中性肽链内切酶抑制剂与缓激肽
Front Med (Lausanne). 2018 Sep 19;5:257. doi: 10.3389/fmed.2018.00257. eCollection 2018.
8
An Optimized Evans Blue Protocol to Assess Vascular Leak in the Mouse.一种评估小鼠血管渗漏的优化伊文思蓝实验方案
J Vis Exp. 2018 Sep 12(139):57037. doi: 10.3791/57037.
9
2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension.2018年欧洲心脏病学会/欧洲高血压学会动脉高血压管理指南：欧洲心脏病学会动脉高血压管理特别工作组和欧洲高血压学会：欧洲心脏病学会动脉高血压管理特别工作组和欧洲高血压学会。
J Hypertens. 2018 Oct;36(10):1953-2041. doi: 10.1097/HJH.0000000000001940.
10
The Absence of the ACE N-Domain Decreases Renal Inflammation and Facilitates Sodium Excretion during Diabetic Kidney Disease.ACE N 端缺失可减少糖尿病肾病时的肾脏炎症并促进钠排泄。
J Am Soc Nephrol. 2018 Oct;29(10):2546-2561. doi: 10.1681/ASN.2018030323. Epub 2018 Sep 5.